Management expects Q1 2025 revenues of $170 million, with a non-GAAP gross margin of 38% at the midpoint of guidance. Non-GAAP EPS is projected at $0.19, reflecting reduced demand in systems, Flash, ...
A 5-star mattress at a 3-star price: Don't let the DreamCloud's boxed bed status and mid-range price fool you. I often recommend it as an alternative to the Saatva Classic if you want a luxury bed ...
The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...
A: The integration of patient perspectives is a major driver. Regulatory bodies are drafting new guidance that compels pharmaceutical companies to embed patient voices into trial design, ensuring real ...
Japanese pharmaceutical company Takeda inaugurated its first Innovation Capability Centre (ICC) in Bengaluru, marking its debut in Asia. The ICC aims to employ 750 professionals, including software ...
SAN FRANCISCO, Jan 16 (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on ...
Pfizer and Intel have sent warnings to the European Chemicals Agency which is considering the move Pfizer pharmaceuticals wrote that a total ban would threaten the viability of this sector.
SO-IL (Solid Objectives – Idenburg Liu) is an architectural design firm based in Brooklyn, New York, founded in 2008 by Florian Idenburg and Jing Liu. Known for an architecture deeply engaged ...
At present, streaming OTT box/sticks & shrewd TVs are the two most normal gadget types for streaming. However, inside every one of these gadget classifications is a few brands battling for a portion ...
A team that includes the University of Washington's David Baker, who picked up his Nobel in Stockholm last month, used software tools to design completely new proteins that are able to inhibit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results